MRSA

Top Story

CDC’s EIS program molds clinicians into public health professionals

Infectious Disease News, June 2017

The man in the hospital in Puerto Rico had been bitten by a mongoose as he reached inside his backyard chicken coop to retrieve some eggs. The mongoose latched on, locking his teeth in the man’s skin, but the man did not seek medical attention. Two months later, in late November 2015, with symptoms of rabies infection, he finally went to the hospital, but the man did not disclose the bite and checked himself out the next morning, against medical advice. He returned later that day and was dead by the evening — the first mongoose-associated rabies fatality in the island’s history.

The Puerto Rico Department of Health, including an embedded officer from the CDC’s Epidemic Intelligence Service (EIS), investigated the case. They put the man’s family on post-exposure prophylaxis and scoured for potentially exposed contacts in his community and among hospital staff. Rabies is common among Puerto Rico’s mongoose population, so Emilio Dirlikov, PhD, a second-year EIS officer, and colleagues needed to make sure residents knew to seek medical attention if they are bitten.

FDA News

FDA approves Baxdela for treatment of ABSSSIs

June 20, 2017
The FDA recently approved an IV and oral formulation of Baxdela, an anionic fluoroquinolone, for the treatment of acute bacterial skin and skin structure infections, or…
In the Journals Plus

HAIs caused by gram-negative bacteria, MRSA increase mortality risk

June 18, 2017
Data from more than 100 hospitals affiliated with the U. S. Department of Veterans Affairs showed that health care-associated infections due to gram-negative bacteria…
Meeting NewsPerspective

Intervention significantly reduces MRSA in Veterans living center

June 16, 2017
Recent findings presented at the Association for Professionals in Infection Control and Epidemiology annual conference showed that an intervention led by the Veterans…
CME CNE CPE

Familial Chylomicronemia Syndrome: Cause, Effect, and Solutions to Improve Patients' Quality-of-Life

This activity is supported by an educational grant from Akcea Therapeutics™ A Subsidiary of Ionis Pharmaceuticals, Inc.
Endorsed by: The National Pancreas Foundation.

Familial chylomicronemia syndrome (FCS) is a rare and potentially life-threatening genetic disease. The clinical…
More »
Meeting News

Taksta noninferior to Zyvox in treating ABSSSIs, including MRSA

June 4, 2017
NEW ORLEANS — Taksta was noninferior to Zyvox as an oral treatment for acute bacterial skin and skin structure…
More »
Featured
ASM Microbe

ASM Microbe

Video
Meeting News Coverage

VIDEO: Experts focus on vaccines to combat antimicrobial resistance

April 26, 2016
More »
Cover Story

CDC’s EIS program molds clinicians into public health professionals

Infectious Disease News, June 2017
The man in the hospital in Puerto Rico had been bitten by a mongoose as he reached inside his backyard chicken coop to retrieve some eggs. The…

FDA News

FDA approves Baxdela for treatment of ABSSSIs

June 20, 2017
The FDA recently approved an IV and oral formulation of Baxdela, an anionic fluoroquinolone, for the treatment of acute bacterial skin and skin…

In the Journals Plus

HAIs caused by gram-negative bacteria, MRSA increase mortality risk

June 18, 2017
Data from more than 100 hospitals affiliated with the U. S. Department of Veterans Affairs showed that health care-associated infections due to…

Meeting NewsPerspective

Intervention significantly reduces MRSA in Veterans living center

June 16, 2017
Recent findings presented at the Association for Professionals in Infection Control and Epidemiology annual conference showed that an intervention…

Meeting News

Infection control drives down MRSA rate in US

June 7, 2017
NEW ORLEANS — Infection control helped drive down the MRSA rate in the United States between 2009 and 2015, according to a researcher who…

Meeting News

Taksta noninferior to Zyvox in treating ABSSSIs, including MRSA

June 4, 2017
NEW ORLEANS — Taksta was noninferior to Zyvox as an oral treatment for acute bacterial skin and skin structure infections, or ABSSSIs…

Meeting News

Baxdela well-tolerated, effective against ABSSSIs

June 3, 2017
NEW ORLEANS — Data from two phase 3 trials demonstrated that IV and oral Baxdela had similar safety and efficacy profiles against acute…

In the Journals

Higher risk of complications for children with MRSA despite lower mortality rate

May 26, 2017
Although mortality rates were lower for children with methicillin-resistant Staphylococcus aureus compared with adults, children experienced more…

Meeting News

Omadacycline noninferior to Zyvox in treating ABSSSIs, including MRSA

April 28, 2017
Treatment of skin infections with the antibiotic omadacycline was noninferior to Zyvox in a phase 3 study, researchers said at the European Congress…

Climate change brings new infectious disease threats

April 22, 2017
Climate change is expected to increase the risk for the spread of numerous types of infectious diseases — including Lyme disease, Zika…

More Headlines »
Advertisement
Advertisement